Publications

What Challenges Will FDA Face In A Post-Chevron World?

Quoted, American Conference Institute

Chad Landmon, Hatch-Waxman & Biologics Chair, discusses the potential challenges the FDA may face in the aftermath of the US Supreme Court’s decision to eliminate the Chevron Doctrine.